Skip to Content
Merck
  • Structural basis for the evolution of vancomycin resistance D,D-peptidases.

Structural basis for the evolution of vancomycin resistance D,D-peptidases.

Proceedings of the National Academy of Sciences of the United States of America (2014-04-09)
Djalal Meziane-Cherif, Peter J Stogios, Elena Evdokimova, Alexei Savchenko, Patrice Courvalin
ABSTRACT

Vancomycin resistance in Gram-positive bacteria is due to production of cell-wall precursors ending in D-Ala-D-Lac or D-Ala-D-Ser, to which vancomycin exhibits low binding affinities, and to the elimination of the high-affinity precursors ending in D-Ala-D-Ala. Depletion of the susceptible high-affinity precursors is catalyzed by the zinc-dependent D,D-peptidases VanX and VanY acting on dipeptide (D-Ala-D-Ala) or pentapeptide (UDP-MurNac-L-Ala-D-Glu-L-Lys-D-Ala-D-Ala), respectively. Some of the vancomycin resistance operons encode VanXY D,D-carboxypeptidase, which hydrolyzes both di- and pentapeptide. The molecular basis for the diverse specificity of Van D,D-peptidases remains unknown. We present the crystal structures of VanXYC and VanXYG in apo and transition state analog-bound forms and of VanXYC in complex with the D-Ala-D-Ala substrate and D-Ala product. Structural and biochemical analysis identified the molecular determinants of VanXY dual specificity. VanXY residues 110-115 form a mobile cap over the catalytic site, whose flexibility is involved in the switch between di- and pentapeptide hydrolysis. Structure-based alignment of the Van D,D-peptidases showed that VanY enzymes lack this element, which promotes binding of the penta- rather than that of the dipeptide. The structures also highlight the molecular basis for selection of D-Ala-ending precursors over the modified resistance targets. These results illustrate the remarkable adaptability of the D,D-peptidase fold in response to antibiotic pressure via evolution of specific structural elements that confer hydrolytic activity against vancomycin-susceptible peptidoglycan precursors.

MATERIALS
Product Number
Brand
Product Description

Supelco
L-Alanine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Pricing and availability is not currently available.
Supelco
L-Alanine, Pharmaceutical Secondary Standard; Certified Reference Material
Pricing and availability is not currently available.
Sigma-Aldrich
L-Alanine, ≥99%
Pricing and availability is not currently available.
Sigma-Aldrich
L-Alanine, BioUltra, ≥99.5% (NT)
Pricing and availability is not currently available.
Sigma-Aldrich
L-Alanine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Pricing and availability is not currently available.
Sigma-Aldrich
L-Alanine, ≥98% (TLC)
Pricing and availability is not currently available.
Alanine, European Pharmacopoeia (EP) Reference Standard
Pricing and availability is not currently available.
Vancomycin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Pricing and availability is not currently available.
Millipore
Vancomycin supplement, suitable for microbiology
Pricing and availability is not currently available.
Sigma-Aldrich
Vancomycin hydrochloride from Streptomyces orientalis, ≥85% (Vancomycin B)
Pricing and availability is not currently available.
Sigma-Aldrich
L-Alanine-12C3, 99.9 atom % 12C
Pricing and availability is not currently available.
Sigma-Aldrich
Vancomycin hydrochloride from Streptomyces orientalis, BioReagent, suitable for plant cell culture
Pricing and availability is not currently available.
Sigma-Aldrich
Vancomycin hydrochloride from Streptomyces orientalis, meets USP testing specifications
Pricing and availability is not currently available.
Sigma-Aldrich
Vancomycin hydrochloride from Streptomyces orientalis, ≥900 μg per mg (as vancomycin base)
Pricing and availability is not currently available.